TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/1/22 18:03 | 10/28/22 | RLAY | Relay Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Porter Andy | MA | O | Chief Ad | S | -10 | 21.54 | 0 | 0 | -1 | 45 | D | ||||||||||||||
9/29/22 17:14 | 9/27/22 | RLAY | Relay Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Porter Andy | MA | O | Chief Ad | S | -6 | 22.73 | 0 | 0 | -1 | 46 | D | ||||||||||||||
7/29/22 16:57 | 7/28/22 | RLAY | Relay Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Porter Andy | MA | O | Chief Ad | S | -10 | 21.27 | 0 | 0 | -1 | 46 | D | ||||||||||||||
6/28/22 18:03 | 6/27/22 | RLAY | Relay Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Porter Andy | MA | O | Chief Ad | S | -5 | 20.31 | 0 | 0 | -1 | 46 | D | ||||||||||||||
5/2/22 20:13 | 4/28/22 | RLAY | Relay Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Porter Andy | MA | O | Chief Ad | S | -11 | 25.57 | 0 | 0 | -1 | 47 | D | ||||||||||||||
3/31/22 17:49 | 3/29/22 | RLAY | Relay Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Porter Andy | MA | O | Chief Ad | S | -9 | 29.87 | 0 | 0 | -1 | 47 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |